CASI PharmaceuticalsCASI
那斯達克 · USD
0.78
+0.03
(+3.82%)
收盤 12/25 01:43 (UTC+8)
12/25 01:43 (UTC+8)
CASI PharmaceuticalsCASI
0.78
+0.03
(+3.82%)
財務數據
損益表
- 0.10
- 0.09
- 0.07
- 0.03
- 0.04
- 0.08
- 0.13
- 0.06
- 0.04
- 0.03
- 17.65
- -10.00
- -22.22
- -50.41
- 16.72
- 95.85
- 71.38
- -53.28
- -33.09
- -26.35
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 3,075 | 4,175 | 6,240 | 13,356 | 7,793 | 3,979 | 3,409 | 6,874 | 8,838 | 9,820 |
營業成本 | 2,369 | 2,117 | 2,621 | 10,128 | 3,748 | 1,912 | 1,603 | 2,815 | 3,648 | 3,986 |
營業毛利 | 706 | 2,058 | 3,619 | 3,228 | 4,045 | 2,067 | 1,806 | 4,059 | 5,190 | 5,834 |
營業費用 | 10,950 | 12,768 | 13,852 | 15,582 | 12,130 | 11,621 | 11,025 | 7,518 | 10,438 | 15,135 |
研發費用 | 1,413 | 1,724 | 1,936 | 3,666 | 1,521 | 1,254 | 2,476 | 2,314 | 2,399 | 2,614 |
推銷及管理費用 | 9,537 | 11,044 | 11,921 | 11,918 | 10,609 | 10,367 | 8,549 | 11,570 | 8,039 | 12,521 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | -5 | - | - | - | - | - | - | - |
營業利益 | -10,244 | -10,710 | -10,233 | -12,354 | -8,085 | -9,554 | -9,219 | -3,459 | -5,248 | -9,301 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 195 | 244 | 197 | - | 204 | 190 | 192 | - | - | - |
稅前純益 | -10,883 | -11,201 | -10,750 | -14,297 | -7,279 | -6,965 | -9,528 | -5,972 | -4,451 | -10,135 |
所得稅 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -81 | 0 | -80 |
稅後純益 | -10,883 | -13,375 | -10,750 | -14,370 | -8,395 | -6,965 | -9,528 | -6,055 | -4,635 | -10,239 |
基本每股稅後盈餘(元) | -0.67 | -0.86 | -0.69 | -0.78 | -0.55 | -0.52 | -0.71 | - | -0.35 | -0.77 |
稀釋每股稅後盈餘(元) | -0.67 | -0.86 | -0.69 | -0.78 | -0.55 | -0.52 | -0.71 | - | -0.35 | -0.77 |
基本平均股數(千股) | 16049.00 | 15505.00 | 15492.00 | 19166.00 | 15294.00 | 13519.00 | 13382.00 | - | 13378.00 | 13344.00 |
稀釋平均股數(千股) | 16049.00 | 15505.00 | 15492.00 | 19166.00 | 15294.00 | 13519.00 | 13382.00 | - | 13378.00 | 13344.00 |
還原基本每股稅後盈餘(元) | -0.67 | -0.86 | -0.69 | -0.78 | -0.55 | -0.52 | -0.71 | - | -0.35 | -0.77 |
還原稀釋每股稅後盈餘(元) | -0.67 | -0.86 | -0.69 | -0.78 | -0.55 | -0.52 | -0.71 | - | -0.35 | -0.77 |
還原基本平均股數(千股) | 16,049 | 15,505 | 15,492 | 19,166 | 15,294 | 13,519 | 13,382 | - | 13,378 | 13,344 |
還原稀釋平均股數(千股) | 16,049 | 15,505 | 15,492 | 19,166 | 15,294 | 13,519 | 13,382 | - | 13,378 | 13,344 |
EBITDA(千元) | -10,688 | -13,131 | -10,553 | -14,370 | -8,191 | -6,775 | -9,336 | -6,136 | -4,635 | -10,319 |